Invention Grant
- Patent Title: Crystalline or amorphous form of steroid derivative FXR agonist, preparation method therefor and use thereof
-
Application No.: US16633111Application Date: 2018-07-26
-
Publication No.: US11059853B2Publication Date: 2021-07-13
- Inventor: Xiaolin Li , Hualing Xiao , Peng Li , Haiying He , Weidong Li
- Applicant: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Applicant Address: CN Lianyungang
- Assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Current Assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Current Assignee Address: CN Lianyungang
- Agency: Knobbe Martens Olson & Bear LLP
- Priority: CN201710619423.5 20170726
- International Application: PCT/CN2018/097161 WO 20180726
- International Announcement: WO2019/020068 WO 20190131
- Main IPC: C07J7/00
- IPC: C07J7/00 ; C07J43/00
Abstract:
Disclosed are a crystalline or amorphous form of steroid derivative FXR agonist (formula I), and a preparation method therefor, and a crystalline composition and pharmaceutical composition comprising the crystalline or amorphous form, and the use of same in the preparation of a drug for treating or preventing various conditions associated with FXR.
Public/Granted literature
Information query
